Revvity Inc. $RVTY Position Trimmed by Asset Management One Co. Ltd.

Key Points

• Asset Management One slashed its stake in Revvity by 90.1%, selling 46,513 shares and retaining 5,109 shares worth about $496,000 per the latest SEC filing.
• Revvity beat quarterly estimates with $1.70 EPS on $772.1M revenue, set FY‑2026 guidance of $5.35–$5.45 EPS, trades near $86.83 with a market cap around $9.7B, and pays a small quarterly dividend of $0.07 (0.3% yield).
• Analyst coverage is mixed: the consensus is a Hold with an average price target of $110.17, amid recent target cuts from Barclays and Goldman and upgrades/raises from others like Evercore and Jefferies.

Asset Management One Co. Ltd. reduced its stake in Revvity Inc. (NYSE:RVTY - Free Report) by 90.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,109 shares of the company's stock after selling 46,513 shares during the period. Asset Management One Co. Ltd.'s holdings in Revvity were worth $496,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the stock. EdgePoint Investment Group Inc. increased its stake in shares of Revvity by 26.3% in the third quarter. EdgePoint Investment Group Inc. now owns 8,574,280 shares of the company's stock valued at $751,536,000 after purchasing an additional 1,784,620 shares during the period. Invesco Ltd. grew its stake in shares of Revvity by 15.7% in the 3rd quarter. Invesco Ltd. now owns 2,553,515 shares of the company's stock worth $223,816,000 after purchasing an additional 346,313 shares during the last quarter. UBS Group AG boosted its stake in shares of Revvity by 22.3% during the 3rd quarter. UBS Group AG now owns 2,179,505 shares of the company's stock worth $191,034,000 after acquiring an additional 397,160 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Revvity by 39.0% during the 3rd quarter. Dimensional Fund Advisors LP now owns 2,125,957 shares of the company's stock worth $186,307,000 after acquiring an additional 596,436 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its stake in Revvity by 127.0% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,751,612 shares of the company's stock valued at $171,921,000 after buying an additional 980,142 shares in the last quarter. 86.65% of the stock is currently owned by institutional investors.

Revvity Trading Down 0.4%

NYSE:RVTY opened at $86.83 on Friday. Revvity Inc. has a 52 week low of $81.36 and a 52 week high of $118.30. The firm has a market cap of $9.71 billion, a P/E ratio of 41.74, a P/E/G ratio of 1.86 and a beta of 1.13. The firm's fifty day moving average is $91.34 and its 200-day moving average is $96.89. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.40 and a current ratio of 1.68.

Revvity (NYSE:RVTY - Get Free Report) last posted its quarterly earnings results on Monday, February 2nd. The company reported $1.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.55 by $0.15. Revvity had a net margin of 8.45% and a return on equity of 7.92%. The business had revenue of $772.06 million during the quarter, compared to the consensus estimate of $759.81 million. During the same quarter last year, the firm posted $1.42 EPS. Revvity's revenue was up 5.9% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. Equities analysts expect that Revvity Inc. will post 5.39 earnings per share for the current year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 8th. Shareholders of record on Friday, April 17th will be given a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend is Friday, April 17th. Revvity's dividend payout ratio is presently 13.46%.

Analyst Upgrades and Downgrades

RVTY has been the topic of several research analyst reports. Barclays reaffirmed an "equal weight" rating and set a $95.00 target price (down from $118.00) on shares of Revvity in a research note on Tuesday, April 14th. TD Cowen restated a "hold" rating on shares of Revvity in a research note on Tuesday, February 3rd. Evercore raised their price objective on shares of Revvity from $112.00 to $118.00 and gave the stock an "outperform" rating in a research note on Tuesday, February 3rd. The Goldman Sachs Group dropped their price target on shares of Revvity from $110.00 to $95.00 and set a "neutral" rating for the company in a research report on Tuesday, April 14th. Finally, Jefferies Financial Group boosted their price target on shares of Revvity from $100.00 to $105.00 and gave the company a "hold" rating in a research report on Monday, February 2nd. Four investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $110.17.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.